Roth Capital Starts Repros Therapeutics (RPRX) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. USO
6. AWK
7. GNK
8. ARGX
9. PLUR
10. RKLB

November 21, 2012 7:21 AM EST
Get Alerts RPRX Hot Sheet
Price: $59.45 +1.45%

Rating Summary:
    12 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Roth Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $19.00.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $13.91 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital